Reparixin

Overview
Catalog #	bs-82515c-5mg
Product Name	Reparixin
Specifications
Storage Buffer	White solid
Storage Condition	-20°C
Target
Product Information	Reparixin is a noncompetitive allosteric inhibitor of IL-8 (CXCL8) activation of CXCR1 and CXCR2 chemokine receptors (IC50 = 1 and 100 nM, respectively). It blocks a number of activities related to IL-8 signaling, including leukocyte recruitment (IC50 = 1 nM) without affecting receptor activation induced by other CXCR1 and CXCR2 agonists.1 In spontaneously hypertensive rats, 5 mg/kg reparixin administered daily for three weeks was shown to reduce blood pressure by inhibiting hypertension-related mediators.2 It attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord.3 Reparixin blockade (100 nM) of CXCR1 has also been used to deplete a cancer stem cell population in human breast cancer cell lines in vitro.4
Description	CAS Number: 266359-83-5 Chemical Name: αR-Methyl-4-(2-methylpropyl)-N-(methylsulfonyl)-benzeneacetamide Molecular weight: 283.39 Formula: C14H21NO3S Solubility: DMSO (100 mg/ml) Ethanol (25 mg/ml) Physical Properties: White solid Purity: 99% by HPLC NMr (Conforms)